<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://hnd.alphagenics.co/blog/hnd-arsa-prohibe-peptidos-sin-registro-acuerdo-602-2026/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-14</news:publication_date><news:title>Honduras prohíbe péptidos sin registro: Acuerdo 602-ARSA-2026</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-bpc-157-tb-500-honduras-evidencia-humana-wada-arsa/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-14</news:publication_date><news:title>BPC-157 y TB-500 en Honduras: evidencia humana, WADA y ARSA</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-peptidos-registrados-arsa-72-productos-consulta-oficial/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-14</news:publication_date><news:title>Péptidos registrados en Honduras: los 72 productos de la ARSA</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-arsa-glp1-noiana-perdida-vision-alerta-honduras/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-13</news:publication_date><news:title>ARSA Honduras alerta por NOIANA y pérdida de visión con GLP-1</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-exosomas-pdrn-estetica-honduras-fda-isp-arsa/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-13</news:publication_date><news:title>Exosomas y PDRN en estética en Honduras: FDA, ISP y ARSA</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-nad-intravenoso-evidencia-antienvejecimiento-honduras/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-13</news:publication_date><news:title>NAD+ intravenoso «antienvejecimiento»: qué muestran los estudios</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-arsa-foro-regional-registro-sanitario-medicamentos/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Registro sanitario en Honduras: foro ARSA y agencia regional</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-colageno-hidrolizado-piel-honduras-metaanalisis-arsa/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Colágeno hidrolizado en Honduras: metaanálisis, financiación y ARSA</news:title></news:news></url><url><loc>https://hnd.alphagenics.co/blog/hnd-ozempic-honduras-naion-fda-ema-riesgo-ocular/</loc><news:news><news:publication><news:name>Alphagenics Honduras</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Ozempic en Honduras: NAION, la FDA y la compra sin receta</news:title></news:news></url></urlset>
